Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Divestments (2018 - 2021)

Serina Therapeutics' Divestments history spans 3 years, with the latest figure at $516000.0 for Q3 2021.

  • For Q3 2021, Divestments changed N/A year-over-year to $516000.0; the TTM value through Dec 2021 reached $466000.0, changed N/A, while the annual FY2021 figure was $466000.0, N/A changed from the prior year.
  • Divestments for Q3 2021 was $516000.0 at Serina Therapeutics, up from -$50000.0 in the prior quarter.
  • Across five years, Divestments topped out at $3.2 million in Q1 2018 and bottomed at -$50000.0 in Q1 2021.
  • The 3-year median for Divestments is $296500.0 (2019), against an average of $939500.0.